Cellooligosaccharide-containing composition
AssigneeAsahi Kasei Chemicals Corporation
InventorsNaoaki YAMASAKI, Ichiro IBUKI, Yoshihito YAGINUMA, Yoshinaga TAMURA
Life of this patent
Estimating the term…
Abstract
Disclosed is a cellooligosaccharide composition comprising, as the main ingredient, at least one cellooligosaccharide selected from the group consisting of cellobiose, cellotriose, cellotetraose, cellopentaose and cellohexaose, which is in the powdery form having an average L/D value of 3.0 or lower, a bulk density of 0.80 g/mL or lower and an angle of repose of 60° or lower.
Claims11
1-30. (canceled)
A cellooligosaccharide-containing quasi-drug, which comprises the cellooligosaccharide-containing composition according to claim 35.
A cellooligosaccharide-containing composition, comprising a cellooligosaccharide composition as an active ingredient in which the cellobiose content is 50% by mass or higher, the content of one or more selected from the group consisting of cellotriose, cellotetraose, cellopentaose, and cellohexaose is 0 to 50% by mass, wherein the cellooligosaccharides are dispersed or dissolved in water or a mixed solution of water/organic solvent.
A cellooligosaccharide-containing composition,
- comprising a cellooligosaccharide composition as an active ingredient, wherein the cellooligosaccharide composition comprises, as a principal ingredient, a cellooligosaccharide comprising cellobiose and one or more selected from the group consisting of cellotriose, cellotetraose, cellopentaose, and cellohexaose and is a powder having an average L/D of 3.0 or lower, a bulk density of 0.80 g/mL or lower, and a repose angle of 60° or smaller, and
- suppressing a decrease in a blood adiponectin concentration to 30% or lower by oral intake thereof.
Dependencies are inferred from the claim text.